Enhancing the Informativeness and Replicability of Imaging Genomics Studies

[1]  M. King,et al.  Genetic Heterogeneity in Human Disease , 2010, Cell.

[2]  J. Ford,et al.  Widespread cortical dysfunction in schizophrenia: the FBIRN imaging consortium. , 2009, Schizophrenia bulletin.

[3]  C. Sabatti,et al.  Multisystem component phenotypes of bipolar disorder for genetic investigations of extended pedigrees. , 2014, JAMA psychiatry.

[4]  N. Freimer,et al.  Endophenotypes for psychiatric disorders: ready for primetime? , 2006, Trends in genetics : TIG.

[5]  Michele T. Diaz,et al.  Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies , 2012, Journal of magnetic resonance imaging : JMRI.

[6]  Thomas E. Nichols,et al.  The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data , 2014, Brain Imaging and Behavior.

[7]  D. Prata,et al.  What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review , 2015, Psychological Medicine.

[8]  C. Carter,et al.  Optimizing the Design and Analysis of Clinical Functional Magnetic Resonance Imaging Research Studies , 2008, Biological Psychiatry.

[9]  I. Deary,et al.  Molecular Genetic Evidence for Genetic Overlap between General Cognitive Ability and Risk for Schizophrenia: A Report from the Cognitive Genomics Consortium (COGENT) , 2013, Molecular Psychiatry.

[10]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[11]  Cameron S. Carter,et al.  Thresholds, Power, and Sample Sizes in Clinical Neuroimaging. , 2016, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[12]  Michael F. Green,et al.  Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: Developing Imaging Biomarkers to Enhance Treatment Development for Schizophrenia and Related Disorders , 2011, Biological Psychiatry.

[13]  Ahmad R. Hariri,et al.  Genetic variation in human NPY expression affects stress response and emotion , 2008, Nature.

[14]  Fabio Sambataro,et al.  Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. , 2011, Archives of general psychiatry.

[15]  Mark E. Schmidt,et al.  The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.

[16]  Peter Kirsch,et al.  Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia. , 2014, JAMA psychiatry.

[17]  M. Munafo,et al.  Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies , 2005, Molecular Psychiatry.

[18]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[19]  Theo G. M. van Erp,et al.  Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: Analysis from the North American Prodrome Longitudinal Study , 2014, NeuroImage.

[20]  C. Carter,et al.  Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. , 2007, Schizophrenia bulletin.

[21]  Mark A. Elliott,et al.  Heritability of Subcortical and Limbic Brain Volume and Shape in Multiplex-Multigenerational Families with Schizophrenia , 2015, Biological Psychiatry.

[22]  D. Boomsma,et al.  Editorial: Genetics of Brain Function and Cognition , 2001, Behavior genetics.

[23]  Daniel R Weinberger,et al.  Intermediate phenotypes in psychiatric disorders. , 2011, Current opinion in genetics & development.

[24]  T. Insel,et al.  Wesleyan University From the SelectedWorks of Charles A . Sanislow , Ph . D . 2010 Research Domain Criteria ( RDoC ) : Toward a New Classification Framework for Research on Mental Disorders , 2018 .

[25]  Michael F. Green,et al.  Identifying Cognitive Mechanisms Targeted for Treatment Development in Schizophrenia: An Overview of the First Meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative , 2008, Biological Psychiatry.

[26]  Randy L. Buckner,et al.  Individual Differences in Amygdala-Medial Prefrontal Anatomy Link Negative Affect, Impaired Social Functioning, and Polygenic Depression Risk , 2012, The Journal of Neuroscience.

[27]  Peter Kochunov,et al.  Genetic basis of neurocognitive decline and reduced white-matter integrity in normal human brain aging , 2013, Proceedings of the National Academy of Sciences.

[28]  Peter Kirsch,et al.  Test–retest reliability of evoked BOLD signals from a cognitive–emotive fMRI test battery , 2012, NeuroImage.

[29]  N. Freimer,et al.  5‐HTTLPR genotype and anxiety‐related personality traits: A meta‐analysis and new data , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  The Simons,et al.  Simons Variation in Individuals Project (Simons VIP): A Genetics-First Approach to Studying Autism Spectrum and Related Neurodevelopmental Disorders , 2012, Neuron.

[31]  Junzhou Huang,et al.  IMAGING GENOMICS. , 2018, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[32]  Christos Davatzikos,et al.  Imaging patterns of brain development and their relationship to cognition. , 2015, Cerebral cortex.

[33]  M. Munafo,et al.  The genetic architecture of psychophysiological phenotypes , 2014, Psychophysiology.

[34]  Nicholas Timpson,et al.  Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease , 2014, Trends in Neurosciences.

[35]  Wendy Bogers,et al.  Automated subcortical segmentation using FIRST: Test–retest reliability, interscanner reliability, and comparison to manual segmentation , 2013, Human brain mapping.

[36]  M. Thun,et al.  Performance of Common Genetic Variants in Breast-cancer Risk Models , 2022 .

[37]  M. Egan,et al.  Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. , 2003, The American journal of psychiatry.

[38]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[39]  Patrick F. Sullivan,et al.  Spurious Genetic Associations , 2007, Biological Psychiatry.

[40]  D. Goldstein,et al.  Uncovering the roles of rare variants in common disease through whole-genome sequencing , 2010, Nature Reviews Genetics.

[41]  T. Insel,et al.  Toward the future of psychiatric diagnosis: the seven pillars of RDoC , 2013, BMC Medicine.

[42]  Brian A. Nosek,et al.  Power failure: why small sample size undermines the reliability of neuroscience , 2013, Nature Reviews Neuroscience.

[43]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[44]  Thomas E. Nichols,et al.  Common genetic variants influence human subcortical brain structures , 2015, Nature.

[45]  C. Bustamante,et al.  GENOME-WIDE ASSOCIATION MAPPING AND RARE ALLELES: FROM POPULATION GENOMICS TO PERSONALIZED MEDICINE - Session Introduction. , 2011, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[46]  J. Callicott,et al.  DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity. , 2013, The Journal of clinical investigation.

[47]  Fabio Sambataro,et al.  Altered Cerebral Response During Cognitive Control: A Potential Indicator of Genetic Liability for Schizophrenia , 2013, Neuropsychopharmacology.

[48]  Russell A. Poldrack,et al.  Guidelines for reporting an fMRI study , 2008, NeuroImage.

[49]  Peter Kirsch,et al.  Hippocampal and Frontolimbic Function as Intermediate Phenotype for Psychosis: Evidence from Healthy Relatives and a Common Risk Variant in CACNA1C , 2014, Biological Psychiatry.

[50]  Marisa O. Hollinshead,et al.  Identification of common variants associated with human hippocampal and intracranial volumes , 2012, Nature Genetics.

[51]  Deanna M Barch,et al.  Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: Biomarkers recommended for further development. , 2012, Schizophrenia bulletin.

[52]  C. Bustamante,et al.  GENOME-WIDE ASSOCIATION MAPPING AND RARE ALLELES: FROM POPULATION GENOMICS TO PERSONALIZED MEDICINE , 2011, PSB 2011.

[53]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[54]  Andreas Meyer-Lindenberg,et al.  False positives in imaging genetics , 2008, NeuroImage.